Explain how the drug interrupts transcription.
Show the impact on the tumour microenvironment.
Differentiate from other mechanisms of action.
Delivered cornerstone asset for global medical education.
Oncologists instantly grasped the dual mechanism action.
Drove deep clinical engagement with upcoming trial data.

By transforming a dense concept into an actionable visual tool, global medical teams easily bridged clinical data and daily practice.

Trusted by some of the world's leading pharmaceutical, biotech and medical communications teams - including AstraZeneca, Pfizer, Sanofi, Takeda, Lundbeck and Samsung Biologics.



















